T- and B-Cell Quantitation and Lymphocyte Proliferation to Antigens and Mitogens Panel
Fees Several factors determine the fee charged to perform a test. Contact your U.S. or International Regional Manager for information about establishing a fee schedule or to learn more about resources to optimize test selection.
Test Classification Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer's instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR), Investigation Use Only (IUO) product, or a Research Use Only (RUO) product.
This test was developed using an analyte specific reagent. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.
CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.
T- and B-Cell Quantitation by Flow Cytometry
86355-B cells, total count
86357-Natural killer (NK) cells, total count
86359-T cells, total count
86360-Absolute CD4/CD8 count with ratio
Lymphocyte Proliferation to Antigens, Blood
Lymphocyte Proliferation to Mitogens, Blood
LOINC® Code Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the result codes returned for this test or profile.
|Result ID||Reporting Name||LOINC Code|
|9336||T-and B-Cell QN by Flow Cytometry(TBBS_)||In Process|
|3321||CD45 Lymph Count, Flow||27071-0|
|32326||Viab of Lymphs at Day 0||In Process|
|32318||Viab of Lymphs at Day 0||In Process|
|32327||Max Prolif of CA as % CD45||69014-9|
|32321||Max Prolif of PWM as % CD45||69019-8|
|3316||% CD3 (T Cells)||8124-0|
|3318||% CD19 (B Cells)||8117-4|
|32322||Max Prolif of PWM as % CD3||69020-6|
|32328||Max Prolif of CA as % CD3||69015-6|
|32329||Max Prolif of TT as % CD45||69029-7|
|32323||Max Prolif of PWM as % CD19||69037-0|
|4054||% CD16+CD56 (NK cells)||18267-5|
|32319||Max Prolif of PHA as % CD45||69038-8|
|32330||Max Prolif of TT as % CD3||69016-4|
|3319||% CD4 (Helper Cells)||8123-2|
|3320||% CD8 (Supp'r Cells)||8101-8|
|32320||Max Prolif of PHA as % CD3||57741-1|
|3322||CD3 (T Cells)||8122-4|
|3324||CD19 (B Cells)||8116-6|
|4055||CD16+CD56 (NK cells)||20402-4|
|3325||CD4 (Helper Cells)||24467-3|
|3326||CD8 (Supp'r Cells)||14135-8|